Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Collaboration
International consortium launches project to develop next generation of vaccines
By
Matt Limb
An international consortium of researchers specializing in human challenge studies is embarking on a $57 million project to develop advanced virus-blocking coronavirus vaccines.
March 15, 2024
Ginkgo Bioworks launches technology network
By
Matt Limb
Ginkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.
March 6, 2024
BioMĂ©rieux, FDA to collaborate on combating food-borne pathogens
By
LabPulse.com staff writers
BioMĂ©rieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Alzheimer’s study results show correlation between blood-based biomarkers and amyloid plaques
By
LabPulse.com staff writers
The first results from the Bio-Hermes study have been released, showing a strong correlation between several blood-based and digital biomarkers with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer's disease (AD).
March 1, 2024
MD Anderson Cancer Center, C-Biomex collaborate on CA9-targeting radioligand
By
Matt Limb
The University of Texas MD Anderson Cancer Center has signed an agreement with South Korean company C-Biomex to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.
February 29, 2024
BioMĂ©rieux, UPitt in new three-year agreement
By
LabPulse.com staff writers
BioMĂ©rieux and the University of Pittsburgh have entered into a three-year diagnostics research agreement, the university announced in Pittwire.
February 2, 2024
IGI, Danaher launch CRISPR gene therapy research center
By
LabPulse.com staff writers
Danaher and the Innovative Genomics Institute (IGI) have launched a collaborative research center aimed at developing CRISPR-based gene therapies for a wide array of diseases.
January 12, 2024
King's College London, bit.bio collaboration launched to build multicell brain models
By
Matt Limb
A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.
December 5, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By
Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
By
Matt Limb
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Pharma companies back project to create largest African ancestry genomics research database
By
Nick Paul Taylor
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
By
LabPulse.com staff writers
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
Page 1 of 6
Next Page